Standard BioTools sells mass cytometry unit to Element Biosystems for $5.5M

Go back to Standard BioTools sells mass cytometry unit to Element Biosystems for $5.5M

Standard BioTools Provides Update on Sale of Mass Cytometry Business

September 30, 2026 4:42 PM EDT

BOSTON, Mass., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) ("Standard BioTools" or the "Company") today announced the following updates in connection with the Companys previously announced merger with Treeline Biosciences, Inc. (Treeline):

Standard BioTools terminated its previously announced agreement to sell its Mass Cytometry Business to Multiplex Bio and entered into a definitive agreement to sell its Mass Cytometry business to Element Biosystems, LLC (Element), an acquisition vehicle formed by GMT Venture Partners, LLC ("GMT Venture") for $5.5 million in cash payable at closing, subject to customary adjustments.

Following the announcement of the... More